Simplex Trading, LLC Alx Oncology Holdings Inc Transaction History

Simplex Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$0.62 - $1.86 $8,789 - $26,367	-14,176 Reduced 97.32%	391 $0
Q4 2024 Feb 11, 2025	SELL	$1.21 - $1.87 $3,120 - $4,822	-2,579 Reduced 15.04%	14,567 $24,000
Q3 2024 Nov 08, 2024	BUY	$1.81 - $8.13 $31,034 - $139,396	17,146 New	17,146 $31,000
Q1 2024 Apr 25, 2024	SELL	$10.95 - $16.79 $47,807 - $73,305	-4,366 Reduced 55.41%	3,514 $39,000
Q4 2023 Feb 02, 2024	SELL	$4.81 - $15.38 $7,599 - $24,300	-1,580 Reduced 16.7%	7,880 $117,000
Q3 2023 Nov 01, 2023	SELL	$4.19 - $7.35 $297 - $521	-71 Reduced 0.74%	9,460 $45,000
Q2 2023 Aug 04, 2023	BUY	$4.37 - $9.56 $41,650 - $91,116	9,531 New	9,531 $71,000
Q4 2022 Feb 02, 2023	BUY	$9.51 - $12.95 $542 - $738	57 New	57 $0
Q2 2021 Aug 12, 2021	SELL	$52.2 - $75.23 $4,906 - $7,071	-94 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$62.84 - $87.68 $5,906 - $8,241	94 New	94 $6,000

31.6M

53.8K

11.7K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $66.8M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.